Ethyl 2-(tert-Butoxycarbonyloxyimino)-2-cyanoacetate
Need Assistance?
  • US & Canada:
    +
  • UK: +

Ethyl 2-(tert-Butoxycarbonyloxyimino)-2-cyanoacetate

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Peptide Synthesis Reagents
Catalog number
BAT-006276
CAS number
1426821-11-5
Molecular Formula
C10H14N2O5
Molecular Weight
242.23
IUPAC Name
ethyl (2E)-2-cyano-2-[(2-methylpropan-2-yl)oxycarbonyloxyimino]acetate
Synonyms
Boc-Oxyma; SCHEMBL17954344; BOC-Oxyma Ethyl 2-(tert-Butoxycarbonyloxyimino)-2-cyanoacetate; DS-19497; J-519916; BOC-Oxyma
Appearance
Off-white to White Crystalline Powder
Purity
98% (HPLC)
Density
1.140±0.10 g/cm3 (20 ºC 760 Torr)
Boiling Point
290.5±23.0 °C (760 Torr)
InChI
InChI=1S/C10H14N2O5/c1-5-15-8(13)7(6-11)12-17-9(14)16-10(2,3)4/h5H2,1-4H3/b12-7+
InChI Key
GTIPXWMOYWXFBG-KPKJPENVSA-N
Canonical SMILES
CCOC(=O)C(=NOC(=O)OC(C)(C)C)C#N
1. Regioselective four-component synthesis of new tetrazolo[1,5-a]quinoline-based 2-amino-1,4-dihydropyridine and pyridin-2(1H)-one derivatives using nano-ZnO catalysis
Tooran Aghaalizadeh, Farough Nasiri Mol Divers. 2018 Nov;22(4):907-917. doi: 10.1007/s11030-018-9844-1. Epub 2018 Jun 27.
Four-component reaction between primary amines, dialkylacetylendicarboxylates, tetrazolo[1,5-a] quinoline-4-carbaldehyde and ethyl-2-cyanoacetate in the presence of 1,4-diaza-bicyclo[2.2.2]octane and zinc oxide nanoparticles results to the regioselective production of new tetrazolo[1,5-a]quinoline-based 2-amino-1,4-dihydropyridine or pyridin-2(1H)-one derivatives in good to high yields. The selectivity of the catalyzed reaction toward the generation of the dihydropyridine or pyridin-2(1H)-one derivatives was found to be strongly dependent on the size of the alkyl groups in the ester moieties of the acetylenic esters. According to single-crystal X-ray diffraction and NMR studies, the pyridin-2(1H)-one derivatives involve a restricted rotation around the C-C bond connecting the tetrazoloquinoline and dihydropyridinone cyclic systems.
2. Expedient approach to synthesis of 4-hydroxy-2-(trifluoromethyl) quinolines through an intramolecular cyclization of ethyl 2-cyano-4,4,4-trifluoro-3 (arylamino)but-2-enoate derivatives
Ali Darehkordi, Mahdiyeh Talebizadeh, Mohammad Anary-Abbasinejad Mol Divers. 2019 May;23(2):307-315. doi: 10.1007/s11030-018-9872-x. Epub 2018 Sep 3.
Ethyl 2-cyano-4,4,4-trifluoro-3-(phenylamino)but-2-enoates have been synthesized by reaction of ethyl 2-cyanoacetate with trifluoroacetimidoyl chloride derivatives using sodium hydride in acetonitrile by conventional and microwave irradiation methods. Then, intramolecular cyclization of these products in nitrobenzene under reflux conditions afforded a new series of substituted (trifluoromethyl)quinoline-3-carbonitrile derivatives in quantitative yields.
3. (E)-2-Cyano-3-(1 H-Indol-3-yl)-N-Phenylacrylamide, a Hybrid Compound Derived from Indomethacin and Paracetamol: Design, Synthesis and Evaluation of the Anti-Inflammatory Potential
Pablo Silva, Maria de Almeida, Jamire Silva, Sonaly Albino, Renan Espírito-Santo, Maria Lima, Cristiane Villarreal, Ricardo Moura, Vanda Santos Int J Mol Sci. 2020 Apr 8;21(7):2591. doi: 10.3390/ijms21072591.
The compound (E)-2-cyano-3-(1H-indol-3-yl)-N-phenylacrylamide (ICMD-01) was designed and developed based on the structures of clinically relevant drugs indomethacin and paracetamol through the molecular hybridization strategy. This derivative was obtained by an amidation reaction between substituted anilines and ethyl 2-cyanoacetate followed by a Knoevenagel-type condensation reaction with indole aldehyde that resulted in both a viable synthesis and satisfactory yield. In order to assess the immunomodulatory and anti-inflammatory activity, in vitro assays were performed in J774 macrophages, and significant inhibitions (p < 0.05) of the production of nitrite and the production of cytokines (IL-1β and TNFα) in noncytotoxic concentrations were observed. The anti-inflammatory effect was also studied via CFA-induced paw edema in vivo tests and zymosan-induced peritonitis. In the paw edema assay, ICMD01 (50 mg kg-1) showed satisfactory activity, as did the group treated with dexamethasone, reducing edema in 2-6 h. In addition, there was no significant inhibition of PGE2, IL-1β or TNFα in vivo. Moreover, in the peritonitis assay that assesses leukocyte migration, ICMD-01 exhibited promising results. Therefore, these preliminary studies demonstrate this compound to be a strong candidate for an anti-inflammatory drug together with an improved gastrointestinal safety profile when compared to the conventional anti-inflammatory drugs.
Online Inquiry
Verification code
Inquiry Basket